PELTHOS THERAPEUTICS INC
PTHS·171126204·US·Common Stock·Healthcare - Biotechnology-Activist
PTHS (PELTHOS THERAPEUTICS INC) is held by 8 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2M), CANTOR FITZGERALD, L. P. ($870,297), GEODE CAPITAL MANAGEMENT, LLC ($321,242). Net institutional sentiment: Bullish.
8
Holders
Avg rating(4 Elite)
$3.4M
Total Value
78% (10)
Fund Consensus
7 buying - 2 selling
Who's Trading
InsiderFMFriedberg Ezra MSell $14KJul 2, 2026
InsiderFMFriedberg Ezra MSell $655.81Jul 2, 2026
InsiderGPGreenleaf PeterSell $19KJul 2, 2026
InsiderGPGreenleaf PeterSell $2KJul 2, 2026
InsiderPMPauls MatthewSell $18KJul 2, 2026
InsiderPMPauls MatthewSell $3KJul 2, 2026
InsiderFMFriedberg Ezra MSell $6KJun 15, 2026
InsiderFMFriedberg Ezra MSell $2KJun 15, 2026
ActivistIKIkarian Capital, LLC7.7%May 15, 2026
Activist3I3i, LP9.9%May 7, 2026
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer